U.S. Food & Drug Administration News: FDA provides update on its ongoing investigation into valsartan products

14Sep - by Editor - 0 - In STL.News



WASHINGTON – The U.S. Food and Drug Administration is updating the public on the agency’s ongoing investigation surrounding the recent voluntary recall of several drug products containing the active pharmaceutical ingredient (API) valsartan, used to treat high blood pressure and heart failure.

The FDA’s latest testing of products shows an additional unexpected impurity in three lots of Torrent Pharmaceuticals’ recalled valsartan drug products.  This second impurity, N-Nitrosodiethylamine (NDEA) is a known animal and suspected human carcinogen. 

Continue reading U.S. Food & Drug Administration News: FDA provides update on its ongoing investigation into valsartan products at STL.News.



Source link